GE HealthCare has received FDA Premarket Authorization for Pristina Recon DL, an innovative 3D mammography reconstruction application. Powered by artificial intelligence (AI), Pristina Recon DL ...

GE HealthCare unveiled Pristina Via, a mammography system aimed at enhancing the screening experience for technologists and patients. Pristina Via gives mammography technologists a suite of tools that ...

CHICAGO--(BUSINESS WIRE)--Today GE HealthCare announced the new Pristina Via™* mammography system designed to enhance the screening experience for both technologists and patients. Debuting at the ...

GE HealthCare’s Pristina Recon DL tool has received pre-market authorisation (PMA) from the US Food and Drug Administration (FDA). Recon DL is a 3D mammography image reconstruction technology ...

"This device is built with comfort in mind," said Patricia Benton with GE Healthcare. "It's built for women, by women." The company brought the equipment to St. Louis as part of a 28-city tour. During ...

MONTREAL--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leader in breast health technology and diagnostics, will feature its latest breast cancer detection technology during the 2024 Society of ...